当前位置：首页 > 文献互助 > 互助详情

Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial复制

飞天小兔神 1个月前 72 10 已完结

1. 系统已在2026-06-09 14:37:30对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1016/S2213-8587(21)00242-4复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213858721002424复制

其他信息:

出版社: Elsevier BV
作者: Hiddo J L Heerspink; Niels Jongs; Glenn M Chertow; Anna Maria Langkilde; John J V McMurray; Ricardo Correa-Rotter; Peter Rossing; C David Sjöström; Bergur V Stefansson; Robert D Toto; David C Wheeler; Tom Greene

上一篇：Risk quanta: an approach to understanding modern financial risk

下一篇：Correction to Lancet Diabetes Endocrinol 2021; 9: 743–54

互助时间线

2026-06-07 09:00:49 [完结求助]

系统完结了求助, 已自动确认了小小猫咪应助的文件是正确的, 求助状态变成 已完结

2026-06-02 14:37:30 [上传文件]

小小猫咪上传了文件(pdf 1.74 MB), 求助状态变成 待确认

2026-06-02 09:00:49 [发起求助]

最新发布的求助

Long-term safety and efficacy of intracortical microstimulation in humans 5分钟前
等离子表面改性实现原位生长高分辨率钙钛矿发光二极管 21分钟前
Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial 33分钟前
Apatinib combined with capecitabine plus temozolomide versus sunitinib in advanced gastroenteropancreatic neuroendocrine tumours: a propensity score-matched real-world study 39分钟前
Biomimetic Shell–Core Nanoparticles Loaded With Apatinib for Dual Starvation and Chemodynamic Combination Therapy of Lung Cancer 40分钟前
Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis 49分钟前
Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial 55分钟前
First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer 57分钟前
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial 1小时前
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer 1小时前
Efficacy and Safety of Fibroblast Growth Factor 21 (FGF21) Analogs in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction … 1小时前
Efimosfermin, a Fibroblast Growth Factor 21 Analogue for Metabolic Dysfunction-Associated Steatohepatitis 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com